VENOUS THROMBOEMBOLISM IN RENALLY IMPAIRED PATIENTS AND DIRECT ORAL ANTICOAGULANTS: The VERDICT Study
Phase of Trial: Phase III
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms VeRDICT
- 16 Nov 2016 Status changed from not yet recruiting to recruiting.
- 11 Aug 2016 Planned initiation date changed from 1 Jun 2016 to 1 Sep 2016.
- 05 Feb 2016 New trial record